Imedex E-learning (audio)

Panel Discussion: Next Line Treatment in CLL - Neil E. Kay, MD

Informações:

Sinopsis

Positioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease